Comprehensive quality of life outcomes with invasive vs. conservative management of chronic coronary disease in the ISCHEMIA trial.
14 Mar, 2022 | 01:27h | UTCComprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA – Circulation (link to abstract – $ for full-text)
Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
Commentary on Twitter
#OriginalResearch: Analysis from the #ISCHEMIA trial showed that chronic #CAD patients with frequent baseline angina reported improvement in QoL when treated with invasive strategy vs conservative management @djc795 @greggwstone @sripalbangalor @DanMarkMD https://t.co/mC8ey8qUCx pic.twitter.com/jF5SiaKdV0
— Circulation (@CircAHA) March 10, 2022